Download PDF Flyer
Alert Subscription
Volume: 1
Editor(s): Atta-ur-Rahman and M. Iqbal Choudhary
DOI: 10.2174/97816080516181100101 eISBN: 978-1-60805-161-8, 2010 ISBN: 978-1-60805-626-2 ISSN: 1879-6656 (Print)
Indexed in: Scopus, Book Citation Index, Science (BKCI-S), Web of Science, BIOSIS Previews, Scopus, EMBASE, Chemical Abstracts, EBSCO, Ulrich's Periodicals.
Recommend this eBook to your Library
“Frontiers in Anti-Cancer Drug Discovery” is an eBook series devoted to publishing the latest and the most important advances in Anti-Cancer drug design and discovery. Eminent scientists write contributions on all areas of rational drug design and drug discovery including medicinal chemistry, in-silico drug design, combinatorial chemistry, high-throughput screening, drug targets, recent important patents, and structure-activity relationships. The eBook series should prove to be of interest to all pharmaceutical scientists involved in research in Anti-Cancer drug design and discovery. Each volume is devoted to the major advances in Anti-Cancer drug design and discovery. The eBook series is essential reading to all scientists involved in drug design and discovery who wish to keep abreast of rapid and important developments in the field.
*(Excluding Mailing and Handling)
Secure Checkout Personal information is secured with SSL technology
Preface promotion: free to download
Pp. i-ii (2)
Atta-ur-Rahman and M. Iqbal Choudhary
Foreword promotion: free to download
Pp. iii
John K. Buolamwini
Contributors promotion: free to download
Pp. iv-ix (6)
Targeting Ribonucleotide Reductase for Cancer Chemotherapy Open Access Plus
Pp. 1-30 (30)
Nuno M.F.S.A. Cerqueira, Pedro A. Fernandes and Maria J. Ramos
Thymidine Phosphorylase/Platelet-Derived Endothelial Cell Growth Factor as a Target for Capecitabine: From Biology to the Bedsid
Pp. 31-54 (24)
Girolamo Ranieri, Aldo Maria Roccaro, Angelo Vacca and Domenico Ribatti
PDF Price: $15
Inhibitors of the Plasminogen Activation System - Promising New Agents for Suppressing Breast Cancer Metastasis Open Access Plus
Pp. 55-78 (24)
Joel D.A. Tyndall, Michael J. Kelso and Marie Ranson
Histone Deacetylase Inhibitors in Cancer Therapy
Pp. 79-115 (37)
Alfredo Budillon, Francesca Bruzzese and Elena Di Gennaro
Second Generation Abl Tyrosine Kinase Inhibitors and Novel Compounds to Eliminate the Bcr-Abl/T315I Clone (Second Edition)
Pp. 116-131 (16)
Shinya Kimura
Aurora Kinase Family: A New Target for Anticancer Drug
Pp. 132-148 (17)
Teresa Macarulla, M. Elena Elez, Francisco Javier Ramos and Josep Tabernero
Molecularly Targeted Therapy in Breast Cancer: The Tyrosine Kinase Inhibitors
Pp. 149-157 (9)
Zeina A. Nahleh
New Perspectives in the Treatment of Melanoma: Anti-Angiogenic and Anti-Lymphangiogenic Strategies
Pp. 158-167 (10)
Caterina A.M. La Porta
Therapeutic Potential of Endogenous Angiogenesis Inhibitors for Cancer Therapy: Historical Perspective and Future Direction
Pp. 168-193 (26)
Mohanraj Dhanabal and Natarajan Sethuraman
Calcium Signals in Endothelium and their Role in the Control of Angiogenesis
Pp. 194-218 (25)
Luca Munaron
Novel Purine Nucleoside Analogues for Hematological Malignancies
Pp. 219-240 (22)
Anna Korycka, Ewa Lech-Maranda and Tadeusz Robak
The Place of Somatostatin Analogs in the Diagnosis and Treatment of the Neuoroendocrine Glands Tumors
Pp. 241-272 (32)
Gabriela Melen-Mucha, Hanna Lawnicka, Dorota Kierszniewska-Stepien, Jan Komorowski and Henryk Stepien
Bortezomib in the Treatment of Cancer
Pp. 273-283 (11)
Aldo M. Roccaro, Angelo Vacca and Domenico Ribatti
Cetuximab: Its Use in Combination with Radiation Therapy and Chemotherapy in the Multimodality Treatment of Head and Neck Cancer
Pp. 284-297 (14)
Timothy D. Wagner and Gary Y. Yang
Platinum-Based Anticancer Agents
Pp. 298-339 (42)
Irena Kostova
c-Myc and Downstream Targets in the Pathogenesis and Treatment of Cancer
Pp. 340-379 (40)
Sam Robson, Inga Pukonen, Sylvie Abouna, Stella Pelengaris and Michael Khan
Small Molecule Vascular Disrupting Agents: Potential New Drugs for Cancer Treatment, a 2009 Update
Pp. 380-427 (48)
Sui Xiong Cai
Developments in Targeted Therapy of Advanced Gastrointestinal Stromal Tumors
Pp. 428-448 (21)
Piotr Rutkowski, Malgorzata Symonides, Marcin Zdzienicki and Janusz A. Siedlecki
Therapeutic Transfer of DNA Encoding Adenoviral E1A†
Pp. 449-464 (16)
Helmut Deissler and Bertram Opalka
Compositions for Treatment of Cancer and Inflammation
Pp. 465-480 (16)
Shahar Lev-Ari, Dov Lichtenberg and Nadir Arber
The Androgen Receptor as Putative Therapeutic Target in Hormone-Refractory Prostate Cancer
Pp. 481-496 (16)
Yukio Kageyama, Nobuhiko Hyochi, Kazunori Kihara and Hiroshi Sugiyama
Older and New Formulations of Cladribine: Pharmacology and Clinical Efficacy in Hematological Malignancies
Pp. 497-524 (28)
Tadeusz Robak, Anna Korycka and Ewa Robak
Developments of New Compounds and New Strategies in the Field of Cytotoxic Nucleoside Analogues
Pp. 525-540 (16)
Lars P. Jordheim and Charles Dumontet
PET in Anti-Cancer Drug Development and Therapy
Pp. 541-551 (11)
Rakesh Kumar, Dhanpathi Halanaik and Saurabh Dahiya
The Anti-Cancer Charm of Flavonoids: A Cup-of-Tea Will Do You Good!
Pp. 552-587 (36)
Amr Amin and Michael Buratovich
Prevention and Treatment of Regimen-Related Mucosal Toxicity
Pp. 588-600 (13)
Joanne M. Bowen
Recent Patents on Bacterial Proteins as Potential Anticancer Agents
Pp. 601-622 (22)
Arsenio M.Fialho and Ananda M.Chakrabarty
Recent Patents on Therapeutic Agents for Cancer
Pp. 623-740 (118)
Xun Li, Yalin Li and Wenfang Xu
Review of Selected Patents for Cancer Therapy Targeting: Tumor Angiogenesis
Pp. 741-757 (17)
Mark N. Kirstein and Arkadiusz Z. Dudek
Targeting Vesicle Trafficking in Cancer Therapeutics
Pp. 758-776 (19)
Paul K. Wright
Author Index to Volume 1 promotion: free to download
Pp. 778-779 (2)
Bentham Science Publishers
view more
